Literature DB >> 25620271

Sphingolipids and mitochondrial apoptosis.

Gauri A Patwardhan1, Levi J Beverly1,2,3, Leah J Siskind4,5.   

Abstract

The sphingolipid family of lipids modulate several cellular processes, including proliferation, cell cycle regulation, inflammatory signaling pathways, and cell death. Several members of the sphingolipid pathway have opposing functions and thus imbalances in sphingolipid metabolism result in deregulated cellular processes, which cause or contribute to diseases and disorders in humans. A key cellular process regulated by sphingolipids is apoptosis, or programmed cell death. Sphingolipids play an important role in both extrinsic and intrinsic apoptotic pathways depending on the stimuli, cell type and cellular response to the stress. During mitochondrial-mediated apoptosis, multiple pathways converge on mitochondria and induce mitochondrial outer membrane permeabilization (MOMP). MOMP results in the release of intermembrane space proteins such as cytochrome c and Apaf1 into the cytosol where they activate the caspases and DNases that execute cell death. The precise molecular components of the pore(s) responsible for MOMP are unknown, but sphingolipids are thought to play a role. Here, we review evidence for a role of sphingolipids in the induction of mitochondrial-mediated apoptosis with a focus on potential underlying molecular mechanisms by which altered sphingolipid metabolism indirectly or directly induce MOMP. Data available on these mechanisms is reviewed, and the focus and limitations of previous and current studies are discussed to present important unanswered questions and potential future directions.

Entities:  

Keywords:  Apoptosis; Bcl-2 proteins; Cancer; Ceramide; Mitochondria; Sphingolipid

Mesh:

Substances:

Year:  2016        PMID: 25620271      PMCID: PMC5434644          DOI: 10.1007/s10863-015-9602-3

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  213 in total

1.  Alteration of the daunorubicin-triggered sphingomyelin-ceramide pathway and apoptosis in MDR cells: influence of drug transport abnormalities.

Authors:  M G Côme; A Bettaieb; A Skladanowski; A K Larsen; G Laurent
Journal:  Int J Cancer       Date:  1999-05-17       Impact factor: 7.396

2.  Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription.

Authors:  Jerry E Chipuk; Ulrich Maurer; Douglas R Green; Martin Schuler
Journal:  Cancer Cell       Date:  2003-11       Impact factor: 31.743

3.  Role of ceramide during cisplatin-induced apoptosis in C6 glioma cells.

Authors:  S Noda; S Yoshimura; M Sawada; T Naganawa; T Iwama; S Nakashima; N Sakai
Journal:  J Neurooncol       Date:  2001-03       Impact factor: 4.130

Review 4.  Discovery of the molecular machinery CERT for endoplasmic reticulum-to-Golgi trafficking of ceramide.

Authors:  Kentaro Hanada
Journal:  Mol Cell Biochem       Date:  2006-06       Impact factor: 3.396

5.  BAK activation is necessary and sufficient to drive ceramide synthase-dependent ceramide accumulation following inhibition of BCL2-like proteins.

Authors:  Levi J Beverly; Lauren A Howell; Maria Hernandez-Corbacho; Lavona Casson; Jerry E Chipuk; Leah J Siskind
Journal:  Biochem J       Date:  2013-05-15       Impact factor: 3.857

6.  Bax distribution into mitochondrial detergent-resistant microdomains is related to ceramide and cholesterol content in postischemic hearts.

Authors:  Eduardo Martínez-Abundis; Francisco Correa; Natalia Pavón; Cecilia Zazueta
Journal:  FEBS J       Date:  2009-08-20       Impact factor: 5.542

7.  Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals.

Authors:  R Bose; M Verheij; A Haimovitz-Friedman; K Scotto; Z Fuks; R Kolesnick
Journal:  Cell       Date:  1995-08-11       Impact factor: 41.582

Review 8.  Ceramide channels and their role in mitochondria-mediated apoptosis.

Authors:  Marco Colombini
Journal:  Biochim Biophys Acta       Date:  2010-01-25

9.  Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, and ceramide.

Authors:  M Chen; J Quintans; Z Fuks; C Thompson; D W Kufe; R R Weichselbaum
Journal:  Cancer Res       Date:  1995-03-01       Impact factor: 12.701

Review 10.  Sphingosine kinase 1 and cancer: a systematic review and meta-analysis.

Authors:  Yun Zhang; Yan Wang; Zhi Wan; Shiping Liu; Yu Cao; Zhi Zeng
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

View more
  41 in total

1.  Decreased ceramide underlies mitochondrial dysfunction in Charcot-Marie-Tooth 2F.

Authors:  Nicholas U Schwartz; Ryan W Linzer; Jean-Philip Truman; Mikhail Gurevich; Yusuf A Hannun; Can E Senkal; Lina M Obeid
Journal:  FASEB J       Date:  2018-01-03       Impact factor: 5.191

Review 2.  Sphingolipids and lipid rafts: Novel concepts and methods of analysis.

Authors:  Erhard Bieberich
Journal:  Chem Phys Lipids       Date:  2018-09-05       Impact factor: 3.329

3.  Liver mitochondrial membrane fluidity at early development of diabetes and its correlation with the respiration.

Authors:  Ismael H Pérez-Hernández; Josué Misael Domínguez-Fuentes; Martín Palomar-Morales; Ana Cecilia Zazueta-Mendizabal; Arturo Baiza-Gutman; Ricardo Mejía-Zepeda
Journal:  J Bioenerg Biomembr       Date:  2017-03-24       Impact factor: 2.945

4.  Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury.

Authors:  Tess V Dupre; Mark A Doll; Parag P Shah; Cierra N Sharp; Deanna Siow; Judit Megyesi; James Shayman; Alicja Bielawska; Jacek Bielawski; Levi J Beverly; Maria Hernandez-Corbacho; Christopher J Clarke; Ashley J Snider; Rick G Schnellmann; Lina M Obeid; Yusuf A Hannun; Leah J Siskind
Journal:  J Lipid Res       Date:  2017-05-10       Impact factor: 5.922

5.  SIRT3 Deacetylates Ceramide Synthases: IMPLICATIONS FOR MITOCHONDRIAL DYSFUNCTION AND BRAIN INJURY.

Authors:  Sergei A Novgorodov; Christopher L Riley; Jarryd A Keffler; Jin Yu; Mark S Kindy; Wendy B Macklin; David B Lombard; Tatyana I Gudz
Journal:  J Biol Chem       Date:  2015-11-30       Impact factor: 5.157

6.  Analysis of sphingolipid composition in human vitreous from control and diabetic individuals.

Authors:  Lynda A Wilmott; Richard C Grambergs; Jeremy C Allegood; Timothy J Lyons; Nawajes Mandal
Journal:  J Diabetes Complications       Date:  2018-12-14       Impact factor: 2.852

Review 7.  The Potential Role of Dietary Platelet-Activating Factor Inhibitors in Cancer Prevention and Treatment.

Authors:  Ronan Lordan; Alexandros Tsoupras; Ioannis Zabetakis
Journal:  Adv Nutr       Date:  2019-01-01       Impact factor: 8.701

8.  Surface modification affect the biodistribution and toxicity characteristics of iron oxide magnetic nanoparticles in rats.

Authors:  Pengfei Yang; Hengyi Xu; Zhihong Zhang; Lin Yang; Huijuan Kuang; Zoraida P Aguilar
Journal:  IET Nanobiotechnol       Date:  2018-08       Impact factor: 1.847

Review 9.  Mitochondrial outer membrane permeabilization at the single molecule level.

Authors:  Shashank Dadsena; Andreas Jenner; Ana J García-Sáez
Journal:  Cell Mol Life Sci       Date:  2021-02-12       Impact factor: 9.261

10.  Systems Approach to Discovery of Therapeutic Targets for Vein Graft Disease: PPARα Pivotally Regulates Metabolism, Activation, and Heterogeneity of Macrophages and Lesion Development.

Authors:  Julius L Decano; Sasha A Singh; Cauê Gasparotto Bueno; Lang Ho Lee; Arda Halu; Sarvesh Chelvanambi; Joan T Matamalas; Hengmin Zhang; Andrew K Mlynarchik; Jiao Qiao; Amitabh Sharma; Shin Mukai; Jianguo Wang; Daniel G Anderson; C Keith Ozaki; Peter Libby; Elena Aikawa; Masanori Aikawa
Journal:  Circulation       Date:  2021-04-06       Impact factor: 39.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.